References
- Levy R. H., Shen D. D. Valproate: absorption, distribution and excretion. Antiepileptic Drugs, R. H. Levy, R. H. Mattson, B. Meldrum. Raven Press, New York 1995; 605–620, and other chapters on Valproate therein
- Tamai I., Tsuji A. Transporter‐mediated permeation of drug across the blood‐brain barrier. J. Pharm. Sci. 2000; 89: 1371–1388
- Amidon G. L., Lennernas H., Shah V. P., Crison J. R. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 1995; 12: 413–420
- Clark D. E. Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. J. Pharm. Sci. 1999; 88: 807–814
- Läbenberg R., Amidon G. L. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New approaches to international regulatory standards. Eur. J. Pharm. Biopharm. 2000; 50: 3–12
- Martindale. The Complete Drug Reference32th Ed., K. Parfitt, S. C. Sweetman, P. S. Blake, A. V. Pearson. The Pharmaceutical Press, London 1999; 362–364
- Uekama K., Hirayama F. Improvement of drug properties by cyclodextrins. The Practice of Medicinal Chemistry, C. Wermuth. Academic Press Limited, New York 1996; 793–825
- Stzejtli J. Medicinal applications of cyclodextrins. Med. Res. Rev. 1994; 14: 353–386
- Serajuddin A. T.M. Solid dispersion of poorly water‐soluble drugs: early promises, subsequent problems, and recent breakthroughs. J. Pharm. Sci. 1999; 88: 1058–1066
- Leuner C., Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm. 2000; 50: 47–60
- Kyowa H. Sodium valproate inclusion. Jpn. Kokai 1981; 81: 133236, Chem. Abstr. 96: 123216
- Klokkers K. Solid, non‐deliquescent formulations of sodium valproate. PCT Int. Appl., WO 9840060 1998, Chem Abstr. 129: 235667
- Irie T., Uekama K. Pharmaceutical applications of cyclodextrins. III. Toxicological issues and safety evaluation. J. Pharm. Sci. 1997; 86: 147–162
- Latrofa A., Trapani G., Franco M., Serra M., Muggironi M., Fanizzi F. P., Cutrignelli A., Liso G. Complexation of phenytoin with some hydrophilic cyclodextrins: effect on aqueous solubility, dissolution rate, and anticonvulsant activity in mice. Eur. J. Pharm. Biopharm. 2001; 52: 65–73
- Trapani G., Latrofa A., Franco M., Pantaleo M. R., Provenzano M. R., Sanna E., Liso G. Dissolution properties and in vivo behaviour of zolpidem in solid dispersions with polyethylene glycols 4000 and 6000. J. Pharm. Sci. 2000; 89: 1443–1451
- Trapani G., Latrofa A., Franco M., Lopedota A., Sanna E., Liso G. Inclusion complexation of propofol with 2‐hydroxypropyl‐β‐cyclodextrin. Physicochemical, nuclear magnetic resonance spectroscopic studies, and anaesthetic properties in rat. J. Pharm. Sci. 1998; 87: 514–518
- Pitha J., Milecki J., Fales H., Pannell L., Uekama K. Hydroxypropyl‐β‐cyclodextrin: preparation and characterization; effects on solubility of drugs. Int. J. Pharm. 1986; 29: 73–82
- Higuchi T., Connors K. A. Phase solubility techniques. Adv. Anal. Chem. Instrum. 1965; 4: 117–212
- Chang Z. L. Sodium valproate and valproic acid. Analytical Profiles of Drug Substances and Excipients, K. Florey. Academic Press, New York 1979; Vol. 8: 529–556
- Khan C. A., Rhodes C. T. The concept of dissolution efficiency. J. Pharm. Pharmacol. 1975; 27: 48–49
- Moore J. W., Flanner H. H. Mathematical comparison of dissolution profiles. Pharm. Tech. 1996; 20: 64–74
- Ma D. Q., Rajewski R. A., VanderVelde D., Stella V. J. Comparative effects of (SBE)7m (β‐CD and HP‐β‐CD on the stability of two antineoplastic agents, melphalan and carmustine. J. Pharm. Sci. 2000; 89: 275–287
- Loftsson T., Magnusdottir A., Masson M., Sigurjonsdottir J. F. Self‐association and cyclodextrin solubilization of drugs. J. Pharm. Sci. 2002; 91: 2307–2316